| Drug Name |
Chlorpromazine |
| Drug ID |
BADD_D00445 |
| Description |
The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class, chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking dopamine receptors. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. |
| Indications and Usage |
For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
N05AA01 |
| DrugBank ID |
DB00477
|
| KEGG ID |
D00270
|
| MeSH ID |
D002746
|
| PubChem ID |
2726
|
| TTD Drug ID |
D01ZII
|
| NDC Product Code |
62332-735; 70518-3175; 63304-083; 63304-114; 62332-738; 62332-737; 63304-122; 62332-739; 63304-143; 62332-736; 63304-185 |
| UNII |
U42B7VYA4P
|
| Synonyms |
Chlorpromazine | Thorazine | Aminazine | Largactil | Chlordelazine | Chlorpromazine Hydrochloride | Hydrochloride, Chlorpromazine | Contomin | Fenactil | Propaphenin | Chlorazine |
